InVivo Therapeutics’ CEO Frank Reynolds Scheduled to Appear on Fox Business Network
CEO to Discuss Latest Advances on July 13th
CAMBRIDGE, Mass. (July 11, 2012) – InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, today announced that CEO Frank Reynolds is scheduled to appear on the Fox Business Network’s program “Markets Now” on Friday, July 13th at approximately 12:40pm EDT. “Markets Now” is a highly rated business network program that airs weekdays from 11:00am to 3:00pm EDT.
InVivo Therapeutics has pioneered a new treatment using a biocompatible polymer-based scaffold to provide structural support to a damaged spinal cord. The device spares spinal cord tissue from scarring while improving functional recovery after a traumatic SCI. In addition to the scaffold and its application for acute and chronic SCI, Reynolds will discuss new hydrogel technologies under development by InVivo.
“Our technology is a true platform that can be leveraged to create many neurotrauma products. InVivo is developing technologies to treat chronic injuries, as well as therapies for other nervous system conditions such as chronic pain due to nerve compression and other peripheral nerve injuries. We’re currently under review at FDA for our first SCI treatment, and we look forward to receiving approval to begin those human studies in 2012,” said Reynolds.